Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress DIHEXA PEPTIDE 10MG VIAL UMBRELLA Labs FDA Drug Approval Stages: From Discovery Through Clinical Trials to Market New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York 2024 FDA approvals exceed average number but have lower sales projections